228 related articles for article (PubMed ID: 8760038)
1. Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats.
Krieger NS; Stathopoulos VM; Bushinsky DA
Am J Physiol; 1996 Jul; 271(1 Pt 1):C130-5. PubMed ID: 8760038
[TBL] [Abstract][Full Text] [Related]
2. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
3. 1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.
Frick KK; Asplin JR; Krieger NS; Culbertson CD; Asplin DM; Bushinsky DA
Am J Physiol Renal Physiol; 2013 Oct; 305(8):F1132-8. PubMed ID: 23926184
[TBL] [Abstract][Full Text] [Related]
4. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.
Karnauskas AJ; van Leeuwen JP; van den Bemd GJ; Kathpalia PP; DeLuca HF; Bushinsky DA; Favus MJ
J Bone Miner Res; 2005 Mar; 20(3):447-54. PubMed ID: 15746989
[TBL] [Abstract][Full Text] [Related]
5. Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats.
Yao JJ; Bai S; Karnauskas AJ; Bushinsky DA; Favus MJ
J Am Soc Nephrol; 2005 May; 16(5):1300-8. PubMed ID: 15788476
[TBL] [Abstract][Full Text] [Related]
6. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption.
Li XQ; Tembe V; Horwitz GM; Bushinsky DA; Favus MJ
J Clin Invest; 1993 Feb; 91(2):661-7. PubMed ID: 8381825
[TBL] [Abstract][Full Text] [Related]
7. Effect of silencing VDR gene in kidney on renal epithelial calcium transporter proteins and urinary calcium excretion in genetic hypercalciuric stone-forming rats.
Xi QL; Wang SG; Ye ZQ; Zhu ZW; Li C; Bai J; Yu X; Liu JH
Urology; 2011 Dec; 78(6):1442.e1-7. PubMed ID: 22137721
[TBL] [Abstract][Full Text] [Related]
8. Hypercalciuria: lessons from studies of genetic hypercalciuric rats.
Favus MJ
J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S54-8. PubMed ID: 7873746
[TBL] [Abstract][Full Text] [Related]
9. Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.
Frick KK; Asplin JR; Culbertson CD; Granja I; Krieger NS; Bushinsky DA
Am J Physiol Renal Physiol; 2014 May; 306(9):F1081-7. PubMed ID: 24573387
[TBL] [Abstract][Full Text] [Related]
10. 1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.
Ng AH; Frick KK; Krieger NS; Asplin JR; Cohen-McFarlane M; Culbertson CD; Kyker-Snowman K; Grynpas MD; Bushinsky DA
Calcif Tissue Int; 2014 May; 94(5):531-43. PubMed ID: 24481706
[TBL] [Abstract][Full Text] [Related]
11. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
[TBL] [Abstract][Full Text] [Related]
12. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
13. The relation between bone and stone formation.
Krieger NS; Bushinsky DA
Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
[TBL] [Abstract][Full Text] [Related]
14. Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.
Frick KK; Krieger NS; Bushinsky DA
Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):336-44. PubMed ID: 26050120
[TBL] [Abstract][Full Text] [Related]
15. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
16. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
Safadi FF; Hermey DC; Popoff SN; Seifert MF
Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
[TBL] [Abstract][Full Text] [Related]
17. Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.
Frick KK; Asplin JR; Favus MJ; Culbertson C; Krieger NS; Bushinsky DA
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F718-26. PubMed ID: 23344574
[TBL] [Abstract][Full Text] [Related]
18. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail.
Bai S; Wang H; Shen J; Zhou R; Bushinsky DA; Favus MJ
J Bone Miner Res; 2010 Apr; 25(4):830-40. PubMed ID: 19929616
[TBL] [Abstract][Full Text] [Related]
19. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
Gensure RC; Antrobus SD; Fox J; Okwueze M; Talton SY; Walters MR
J Bone Miner Res; 1998 Mar; 13(3):454-63. PubMed ID: 9525346
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor (VDR) contributes to the development of hypercalciuria by sensitizing VDR target genes to vitamin D in a genetic hypercalciuric stone-forming (GHS) rat model.
Guo S; Chia W; Wang H; Bushinsky DA; Zhong B; Favus MJ
Genes Dis; 2022 May; 9(3):797-806. PubMed ID: 35782986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
